- Home
- CHDN vs APLS Comparison
CHDN vs APLS Comparison
Compare CHDN & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHDN | APLS |
|---|---|---|
| Founded | 1928 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.2B |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CHDN | APLS |
|---|---|---|
| Price | $85.30 | $41.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 21 |
| Target Price | ★ $138.44 | $33.59 |
| AVG Volume (30 Days) | 922.9K | ★ 7.5M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.43% | N/A |
| EPS Growth | N/A | ★ 112.50 |
| EPS | ★ 5.49 | 0.15 |
| Revenue | ★ $1,809,800,000.00 | $1,003,782,000.00 |
| Revenue This Year | $5.75 | N/A |
| Revenue Next Year | $3.52 | $18.19 |
| P/E Ratio | ★ $15.58 | $273.60 |
| Revenue Growth | 13.31 | ★ 28.46 |
| 52 Week Low | $81.66 | $16.61 |
| 52 Week High | $118.46 | $41.14 |
Technical Indicators
Market Signals| Indicator | CHDN | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 84.57 |
| Support Level | $83.19 | $19.29 |
| Resistance Level | $88.33 | $41.14 |
| Average True Range (ATR) | 2.51 | 0.06 |
| MACD | -0.61 | -0.65 |
| Stochastic Oscillator | 15.21 | 58.33 |
Price Performance
Historical ComparisonAbout CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).